Ulcerative Colitis Clinical Trials in Houston

Showing 281-300 of 336 trials

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

NCT01609062

The primary objective of this study was to evaluate the safety of a 2.0 mg/kg/week and a 4.0 mg/kg/week of BMN 110 in patients with Morquio A syndrome for up to 196 weeks. Secondary objectives were to investigate the effect of the two doses on exercise capacity for up to 196 weeks. In addition, the pharmacokinetic (PK) parameters of both doses of BMN 110 was assessed.

Mucopolysaccharidosis IVAMorquio A SyndromeMPS IVA

BioMarin Pharmaceutical25 participantsStarted Apr 2012

Oakland, California, United States • Chicago, Illinois, United States • New York, New York, United States +8 more locations

COMPLETEDPHASE2< 1 mile

Dose Ranging Study

NCT01802723

Dose Ranging Study

Periumbilical Subcutaneous Adipose Tissue Reduction

Neothetics, Inc472 participantsStarted Feb 2013

Beverly Hills, California, United States • Encinitas, California, United States • Los Angeles, California, United States +19 more locations

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

Dose Ranging Study

Ulcerative Colitis Trials in Other Cities

Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension

Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy

Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma

Tiotropium / Respimat One-Year Study

A Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Tiotropium / Respimat One Year Study in COPD.

Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)

Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)

12 / 48 Week Pivotal PFT vs PBO in COPD I

NVA237 BID Versus Placebo Twelve-week Efficacy Study

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)

Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients

Surgical Reduction of the Inferior Turbinates for Nasal Obstruction

Other Conditions in Houston